Abstract
Abstract: Mesenchymal Stem Cells (MSCs), a self-renewing and multipotent population of cells have proved to be a potential regenerative medical therapy option. Initially, it was assumed that the primary mechanism behind MSCs action was cell substitution by differentiation and engraftment at the injury site. However, recent trials have demonstrated that implanted cells don’t last long and that the benefits of MSCs therapy may be triggered by a wide number of bioactive factors, essential for regulating main biological processes. Thus, supporting the paracrine mechanism of action of MSCs. Application of secretome could eliminate the potential risk factors associated with MSCs transplantation, like the unknown fate of cells after transplantation, malignant transformation, and undesired differentiation of MSCs. However, the use of a secretome might not give long-lasting and desired results. Thus, it may intuitively suggest the need for other treatment options. The cellular lysate is considered as an alternate cell-free treatment strategy for the cure of multiple disorders. The present review describes the MSCs secretome/extracellular vesicles and MSCs lysate, derived from bone marrow and adipose, as a cell-free therapy with the application of MSCs lysate for various diseases from 2010 to 2020. Moreover, it also highlights the advantages and limitations of each cell-free therapy.
Keywords: Stem cells, cell lysate, mesenchymal stem cells (MSCs), cell-free therapy, bioactive factors, regenerative medicine.
Current Biotechnology
Title:Mesenchymal Stem Cells Lysate as a Cell-Free Therapy: A Review
Volume: 10 Issue: 2
Author(s): Sabeen Malik*Tehreem Malik
Affiliation:
- Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan
Keywords: Stem cells, cell lysate, mesenchymal stem cells (MSCs), cell-free therapy, bioactive factors, regenerative medicine.
Abstract: Abstract: Mesenchymal Stem Cells (MSCs), a self-renewing and multipotent population of cells have proved to be a potential regenerative medical therapy option. Initially, it was assumed that the primary mechanism behind MSCs action was cell substitution by differentiation and engraftment at the injury site. However, recent trials have demonstrated that implanted cells don’t last long and that the benefits of MSCs therapy may be triggered by a wide number of bioactive factors, essential for regulating main biological processes. Thus, supporting the paracrine mechanism of action of MSCs. Application of secretome could eliminate the potential risk factors associated with MSCs transplantation, like the unknown fate of cells after transplantation, malignant transformation, and undesired differentiation of MSCs. However, the use of a secretome might not give long-lasting and desired results. Thus, it may intuitively suggest the need for other treatment options. The cellular lysate is considered as an alternate cell-free treatment strategy for the cure of multiple disorders. The present review describes the MSCs secretome/extracellular vesicles and MSCs lysate, derived from bone marrow and adipose, as a cell-free therapy with the application of MSCs lysate for various diseases from 2010 to 2020. Moreover, it also highlights the advantages and limitations of each cell-free therapy.
Export Options
About this article
Cite this article as:
Malik Sabeen *, Malik Tehreem , Mesenchymal Stem Cells Lysate as a Cell-Free Therapy: A Review, Current Biotechnology 2021; 10 (2) . https://dx.doi.org/10.2174/2211550110666210617093954
DOI https://dx.doi.org/10.2174/2211550110666210617093954 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
Call for Papers in Thematic Issues
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors
Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse ...read more
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases
In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds ...read more
Feeding a vegan World
The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the ...read more
Leveraging AI for personalized pediatric neurodevelopmental support
Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials In Vivo Measurement in Pigs of Wash-In Kinetics of Xenon at its Site of Action
Current Clinical Pharmacology Serum Vitamin E (α-Tocopherol) Estimation: A Potential Biomarker of Antioxidant Status Evaluation on Heavy Metal Toxicities
Recent Patents on Biomarkers P Wave Morphology in Guiding the Ablation Strategy of Focal Atrial Tachycardias and Atrial Flutter
Current Cardiology Reviews Cortical and Putamen Age-Related Changes in the Microvessel Density and Astrocyte Deficiency in Spontaneously Hypertensive and Stroke-Prone Spontaneously Hypertensive Rats
Current Neurovascular Research 24-Hour Blood Pressure Control – A Predictor for Clinical Outcomes
Current Hypertension Reviews Matrix Metalloproteinases in Lung Diseases
Current Protein & Peptide Science Book Review: Drug Delivery to the Brain-Physiological Concepts, Methodologies and Approaches
Current Drug Delivery Analysis of Chemical Composition by GC-MS and In-vitro Antidiabetic Activity of Azadirachta Indica Leaves Collected from Erbil, Iraq
Current Traditional Medicine Prevalence of Neuropsychiatric Symptoms in Alzheimers Disease and Vascular Dementia
Current Alzheimer Research The Enigmatic Drug Binding Site for Sodium Channel Inhibitors
Current Molecular Pharmacology Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Macrophage-Derived Foam Cells in Atherosclerosis: Lessons from Murine Models and Implications for Therapy
Current Drug Targets Clearance of Amyloid-β Peptide Across the Choroid Plexus in Alzheimer's Disease
Current Aging Science Editorial [Hot Topic:The Metabolic Treatment of Coronary Artery Disease and Heart Failure(Executive Editor: Pericle Di Napoli)]
Current Pharmaceutical Design Indications for Heart Transplantation in Congenital Heart Disease
Current Cardiology Reviews Elevated Levels of Soluble Fibrin in Patients with Thrombosis or a Pre- Thrombotic State
Vascular Disease Prevention (Discontinued) QSAR of the Anticonvulsant Enaminones; Molecular Modeling Aspects and other Assessments
Medicinal Chemistry Redox-signalling and Redox Biomarkers in Cardiovascular Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry